XGXiaoying Guo

Xiaoying Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoying Guo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Fujing Man

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Hao Lv

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Junping Zhang

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China

    1 shared publication
  • Qi Shi

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Wanqin Zhang

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication
  • Yaping Zhu

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

    1 shared publication

Latest Publications

  • Lipid Droplet—a New Target in Ischemic Heart Disease

    by Xiaoying Guo, Qi Shi, Wanqin Zhang, Zhongwen Qi, Hao Lv, Fujing Man, Yingyu Xie, Yaping Zhu, Junping Zhang

    Lipid droplet (LD) is a kind of subcellular organelle, which originates from the endoplasmic reticulum (ER). LDs can move flexibly between other organelles and store energy in the cells. In recent years, LDs and lipid droplet–associated proteins have attracted added attention at home and abroad, especially in cardiovascular diseases. Cardiovascular diseases, especially ischemic heart disease (IHD), have always been the focus of attention because of their high morbidity and mortality. Atherosclerosis and myocardial remodeling are two important pathologic processes of IHD, and LDs and other organelles are involved in the development of the disease. The interaction between LDs and ER is involved in the formation of foam cells in atherosclerosis. And LDs, mitochondria, and lysosomes also affect the remodeling of cardiomyocytes by affecting ROS production and regulating PI3K/AKT pathways. In this article, we will review the role of LDs in IHD. Graphical abstract